Manufacturer Recalls Vasopressin Injection USP, Multiple Dose Vials

August 11, 2011 12:18 pm

A nationwide voluntary recall of multiple lots of Vasopressin Injection, USP to the retail and hospital level has been initiated by American Regent, Inc, because some vials may not maintain potency throughout their shelf-life. Solutions that are below potency limits may have reduced effectiveness if administered. The products were distributed to wholesalers and distributors nationwide and affected lot numbers are listed in an American Regent press release. The manufacturer notes that hospitals, infusion centers, clinics, retail pharmacies, and other health care facilities should not use American Regent, Inc, Vasopressin Injection, USP Multiple Dose Vials with the lot numbers listed in the press release and should immediately quarantine any product for return to American Regent, Inc. Instructions for returning products from recalled lots are also included in the press release.